• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of clinexpimmunolLink to Publisher's site
Clin Exp Immunol. Mar 1996; 103(3): 408–413.
PMCID: PMC2200361

Natural killer (NK) cell deficiency associated with an epitope-deficient Fc receptor type IIIA (CD16-II)


Susceptibility to herpes virus infections has been described in experimental animals depleted of NK cells and in patients with defective NK cell function. We have identified a child with recurrent infections, especially with herpes simplex virus, who had a decreased number of CD56+CD3 NK cells in circulation. Her NK cells expressed an altered form of the Fc receptor for IgG type IIIA (FcγRIIIA or CD16-II) which was not reactive with the anti-CD16-II MoAb B73.1. Sequence analysis revealed the patient to be homozygous for a T to A substitution at position 230 of CD16-II cDNA, predicting a Leu66 to His66 change in the first immunoglobulin domain of CD16-II at the B73.1 recognition site. Spontaneous NK cell activity of the patient's peripheral blood mononuclear cells (PBMC) was markedly decreased, while antibody-dependent cellular cytotoxicity (ADCC) was unaffected. These results suggest that this child suffers from a defect affecting the development and function of NK cells, resulting in NK cytopenia and clinically significant immunodeficiency. The role of the CD16-II mutant in the pathogenesis of the patient's NK cell deficiency is discussed.

Keywords: immunodeficiency, natural killer cells, Fc receptors, CD16, herpes viruses

Full Text

The Full Text of this article is available as a PDF (779K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
1. Trinchieri G. Biology of natural killer cells. Adv Immunol. 1989;47:187–37. [PubMed]
2. Lopez C, Kirkpatrick D, Fitzgerald P. In: The role of NK (HSV-1) effector cells in the resistance to herpes virus infections in man, in NK cells and other effector cells. Herberman RB, editor. New York: Academic Press; 1982.
3. Quinnan GVJ, Kirmani N, Rook AH. Cytotoxic T cells in cyto-megalovirus infection: HLA-restricted T-lymphocyte and non-T-lymphocyte cytotoxic responses correlate with recovery from cytomegalovirus infection in bone-marrow-transplant recipients. N Engl J Med. 1982;307:7–13. [PubMed]
4. Bukowsky JF, Woda BA, Habu S, Okumura K, Welch RM. Natural killer cell depletion enhances virus synthesis and virus-induced hepatitis in vivo. J Immunol. 1983;131:1531–8. [PubMed]
5. Habu S, Akamatsu K, Tamaoki N, Okumura In vivo significance of NK cell on resistance against virus (HSV-1) infections in mice. J Immunol. 1984;133:2743–7. [PubMed]
6. Bukowski JF, Warner JF, Dennert G, Welsh RM. Adoptive transfer studies demonstrating the antiviral effect of natural killer cells In vivo. J Exp Med. 1985;161:40–52. [PMC free article] [PubMed]
7. Garcia-Penarrubia P, Koster FT, Kelly RO, McDowell TD, Bank-hurst AD. Antibacterial activity of human natural killer cells. J Exp Med. 1989;169:99–113. [PMC free article] [PubMed]
8. Biron CA, Byron KS, Sullivan JL. Severe herpesvirus infections in an adolescent without natural killer cells. N Engl J Med. 1989;320:1731–5. [PubMed]
9. Ballas ZK, Turner JM, Turner DA, Goetzman BA, Kemp JD. A patient with simultaneous absence of ‘classical’ natural killer cells (CD3, CD16, and NKH1+) and expansion of CD3+, CD4, CD8, NKH1+ subset. J Allergy Clin Immunol. 1990;85:453–9. [PubMed]
10. Lanier LL, Testi R, Bindl J, Philips JH. Identity of Leu19 (CD56) leukocyte differentiation antigen and neural cell adhesion molecule (N-CAM) J Exp Med. 1989;169:2233–8. [PMC free article] [PubMed]
11. Lanier LL, Chang C, Azuma M, Ruitenberg JJ, Hemperly JJ, Philips JH. Molecular and functional analysis of human natural killer cell-associated neural cell adhesion molecule (N-CAM/ CD56) J Immunol. 1991;146:4421–6. [PubMed]
12. Ravetch JV, Kinet J-P. Fc receptors. Annu Rev Immunol. 1991;9:457–92. [PubMed]
13. Ravetch JV, Perussia B. Alternative membrane forms of FcγRIII (CD16) on human NK cells and neutrophils: cell-type specific expression of 2 genes which differ in single nucleotide substitutions. J Exp Med. 1989;170:481–97. [PMC free article] [PubMed]
14. Selvaraj P, Rosse WF, Silber R, Springer TA. The major Fc receptor in blood has a phosphatidylinositol anchor and is deficient in paroxysmal nocturnal hemoglobinuria. Nature. 1988;333:565–7. [PubMed]
15. Simmons D, Seed B. The FcγR of natural killer cells is a phospho-lipid-linked membrane protein. Nature. 1988;333:568–70. [PubMed]
16. Huizinga TWJ, Van der Schoot CE, Jost C, et al. The PI-linked receptor FcγRIII is released on stimulation of neutrophils. Nature. 1988;333:667–9. [PubMed]
17. Selvaraj P, Carpen O, Hibbs ML, Springer TA. Natural killer cell and granulocyte FcγRIII (CD16) differ in membrane anchor and signal transduction. J Immunol. 1989;143:3283. [PubMed]
18. Finberg RW, Newburger JW, Mikati MA, Heller AH, Burns JC. Effects of high doses of intravenously adminstered immune globulin on natural killer cell activity in peripheral blood. J Peds. 1992;120:376–80. [PubMed]
19. Anderson CL, Looney RJ, Clup DJ, et al. Human alveolar and peritoneal macrophages bear three distinct classes of Fc receptors for IgG. J Immunol. 1990;145:196. [PubMed]
20. Perussia B, Trinchieri G, Jackson A, et al. The Fc receptor for IgG on human natural killer cells: phenotypic, functional, and comparative studies with monoclonal antibodies. J Immunol. 1984;133:180–9. [PubMed]
21. Griffin JD, Ritz J, Nadler LM, Schlossman SF. Expression of myeloid differentiation antigens on normal and malignant myeloid cells. J Clin Invest. 1981;68:932–41. [PMC free article] [PubMed]
22. Caligiuri MA, Zmuidzians A, Manely TJ, Levine H, Smith KA, Ritz J. Functional consequences of interleukin 2 receptor expression on resting human lymphocytes. Identification of a novel natural killer cell subset with high affinity receptors. J Exp Med. 1990;171:1509–26. [PMC free article] [PubMed]
23. Nagler A, Lanier LL, Philips JH. Constitutive expression of high affinity interleukin 2 receptors on human CD16 natural killer cells in vivo. J Exp Med. 1990;171:1527–33. [PMC free article] [PubMed]
24. Hibbs ML, Tolvanen M, Carpen O. Membrane-proximal Ig-like domain of FcγRIII (CD16) contains residues critical for ligand binding. J Immunol. 1994;152:4466–74. [PubMed]
25. Scallon BJ, Scigliano E, Freedman VH, Miedel MC, Pan Y-CE, Unkless JC, Kochan JP. A human immunoglobulin G receptor exists in both polypeptide-anchored and phosphatidylinositol-glycan-anchored forms. Proc Natl Acad Sci USA. 1989;86:5079–83. [PMC free article] [PubMed]
26. Lanier LL, Cwirla S, Yu G, Testi R, Philips JH. Membrane anchoring of a human IgG Fc receptor (CD16) determined by a single amino acid. Science. 1989;246:1611–3. [PubMed]
27. Trounstine ML, Peltz GA, Yssel H, Huizinga TWJ, von dem Borne AEK, Spits H, Moore K. Reactivity of cloned, expressed human FcγRIII isoforms with monoclonal antibodies which distinguish cell-type specific and allelic form of FcγRIII. Int Immunol. 1990;2:303–10. [PubMed]
28. Peltz GA, Grundy HO, Lebo RV, Yessel H, Brash GS, Moore KW. Human Fc gamma RIII: cloning, expression and identification of an Fc-gamma receptor chromosomal locus. Proc Natl Acad Sci USA. 1989;86:1013–7. [PMC free article] [PubMed]
29. Hibbs ML, Selvaraj P, Capen O, Springer OA, Kuster H, Jouvin M, Kinet J-P. Mechanisms for regulating expression of membrane isoforms of FcγRIIIA (CD16) Science. 1989;246:1608–11. [PubMed]
30. de Vries E, Van Tol MJD, Koene HR, De Haas M, von dem Borne AEGK, Gratama JW, Vossen JM. Proc. of the 9th International Congress of Immunology. San Francisco, CA: 1995. A patient with recurrent infections associated with an aberrant Fc receptor (CD16) molecule on natural killer cells. (Abstr. 2267.)
31. Leibson PJ. MHC-recognizing receptors: they're not just for T cells any more. Immunity. 1995;3:5–8. [PubMed]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology


Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...


  • Cited in Books
    Cited in Books
    PubMed Central articles cited in books
  • MedGen
    Related information in MedGen
  • OMIM
    OMIM record citing PubMed
  • PubMed
    PubMed citations for these articles
  • Substance
    PubChem Substance links

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...